Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial

已完结 10 由 wayne 发布于 2026/6/1 16:53:06

DOI:10.1016/s2213-8587(25)00226-8
作者：Sean Wharton, Paula Freitas, J?ran Hjelmes?th, Maria Kabisch, Kristian Kandler, Ildiko Lingvay, Maria Quiroga, Julio Rosenstock, W Timothy Garvey
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundOnce-weekly subcutaneous semaglutide 2·4 mg is approved for weight management in people with obesity and related complications; however, some individuals do not reach their therape

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyApplied paleoecology for macrophyte restoration: Defining Anthropocene baselines in Lake Liangzi